ERK inhibitor
An ERK inhibitor refers to a class of compounds or molecules designed to block the activity of extracellular signal-regulated kinase (ERK), a crucial protein kinase in the MAPK signaling pathway. ERK plays a pivotal role in various cellular processes, including proliferation, differentiation, survival, and motility. Dysregulation of the ERK pathway is implicated in several diseases, including cancers, where it promotes uncontrolled cell growth and survival. ERK inhibitors work by binding to ERK or interfering with upstream signaling molecules to prevent ERK activation. By inhibiting ERK activity, these inhibitors aim to suppress aberrant cell signaling pathways, thereby potentially halting cancer progression or treating other ERK-dependent disorders.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:3 Page 1 of 1 1
![2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one](http://file1.lookchem.com/300w/substances/2022-02-14-05/47210272-fd4f-4980-8a6b-9b27f4af9ece.png)
![5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine](http://file1.lookchem.com/300w/substances/2022-02-14-05/c3e911ba-b97c-481b-942b-748580c5cb55.png)